Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hyphens Pharma InternationalSGX:1J5 -2.70%82 Days Inventory is 102.10 as of Jun. 2026, which is 40% above its 10-year median of 72.69. GuruFocus rates SGX:1J5 with a GF Score™ of 82/100 and a GF Value™ of S$0.31 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 119 Medical Distribution companies, Hyphens Pharma International ranks worse than 75.63% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Hyphens Pharma International's Inventory Turnover for the
six
months ended in Jun. 2026 was 1.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hyphens Pharma International's Inventory-to-Revenue for the
six
months ended in Jun. 2026 was 0.32.
Hyphens Pharma International (SGX:1J5) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Hyphens Pharma International's Inventory Turnover for the
six
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Hyphens Pharma International's Inventory to Revenue for the
six
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Hyphens Pharma International Days Inventory Related Terms
Hyphens Pharma International Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:1J5 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Hyphens Pharma International's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyphens Pharma International Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hyphens Pharma International's Days Inventory distribution charts can be found below:
* The bar in red indicates where Hyphens Pharma International's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hyphens Pharma International (SGX:1J5) has a Days Inventory of 102.10 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hyphens Pharma International and its competitors. This is 40% above median its historical median of 72.69. Over the past decade, Hyphens Pharma International's Days Inventory has ranged from 42.19 to 110.66. According to the industry distribution chart, Hyphens Pharma International ranks #90 out of 119 companies in the Medical Distribution industry, placing it in the top 75.6%.
Is Hyphens Pharma International's Days Inventory too high?
Hyphens Pharma International's current Days Inventory of 102.10 is 40% above median its 10-year median of 72.69. Over the past 10 years, this metric has ranged from a low of 42.19 to a high of 110.66. The Medical Distribution industry median Days Inventory is 55.31. Hyphens Pharma International's value of 102.10 is 84.6% above this industry median. Based on the distribution chart, Hyphens Pharma International ranks #90 out of 119 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Hyphens Pharma International has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hyphens Pharma International's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Hyphens Pharma International ranks #90 out of 119 companies for Days Inventory. This places Hyphens Pharma International in the lower half of its industry. The industry median Days Inventory is 55.31. Hyphens Pharma International's value of 102.10 is 84.6% above this benchmark. Historically, Hyphens Pharma International's own Days Inventory has ranged from 42.19 to 110.66 over the past decade. While the company's 10-year median is 72.69 vs. the industry median of 55.31, Hyphens Pharma International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 55.31, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hyphens Pharma International's current Days Inventory of 102.10 is 84.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Hyphens Pharma International and its competitors. For the Medical Distribution industry, the median Days Inventory is 55.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyphens Pharma International's current Days Inventory is 102.10, which is 40% above median its own 10-year median of 72.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyphens Pharma International stock overvalued right now?
Based on GuruFocus' analysis, Hyphens Pharma International (SGX:1J5) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.31, compared to a current price of S$0.36 — trading 16.1% above its estimated fair value. The current Days Inventory is 102.10, which is 40% above median its 10-year median of 72.69 and 84.6% above the Medical Distribution industry median of 55.31. Hyphens Pharma International's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Hyphens Pharma International (SGX:1J5), the current Days Inventory is 102.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyphens Pharma International (SGX:1J5) Overvalued in 2026?
Based on GuruFocus' analysis, Hyphens Pharma International stock appears to be overvalued.
The current stock price of S$0.36 is trading 16.1% above its estimated GF Value™ of S$0.31.
GuruFocus considers Hyphens Pharma International to be Modestly Overvalued.
Key valuation signals for SGX:1J5:
Days Inventory: 102.10 (40% above median its 10-year median of 72.69)
GF Value™: S$0.31 vs. price of S$0.36 (16.1% above fair value)
Industry Position: 84.6% above the Medical Distribution median (#90 of 119)
No single metric tells the full story. See the SGX:1J5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include the Pharmaceutical and Medical Aesthetics segment; Proprietary Brands segment; and Digital Platform and E-Pharmacy segment. The Pharmaceutical and Medical Aesthetics segment engages in the business of marketing and selling a range of pharmaceutical and medical aesthetics products with exclusivity in the relevant ASEAN countries. The Proprietary Brands segment develops, markets, and sells dermatological, pharmaceuticals and health supplement products. The Digital Platform and E-Pharmacy segment is a digital platform servicing procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies, mainly in Singapore.
82GF Score
Get the complete analysis for SGX:1J5
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1J5 has been successfully added to your 
